Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1082-1087. doi: 10.19723/j.issn.1671-167X.2020.06.015

Previous Articles     Next Articles

Association between CMTM5 gene and coronary artery disease and the relative mechanism

Teng-fei LIU,Tao LIN,Li-hui REN,Guang-ping LI,Jian-jun PENG()   

  1. Department of Cardiology, Beijing Shijitan Hospital of Capital Medical University, Beijing 100034, China
  • Received:2018-12-13 Online:2020-12-18 Published:2020-12-13
  • Contact: Jian-jun PENG E-mail:pjj1972@sina.com
  • Supported by:
    Foundation of Research and Development Plan of China Railway Corporation(J2017Z608);Youth Foundation(2017-q27);Open Research Funding of Central Laboratory of Beijing Shijitan Hospital Affiliated to the Capital Medical University(2019-KF28)

RICH HTML

 5   

PDF (PC)

111

Abstract:

Objective: To elucidate the correlation between CKLF-like MARVEL transmembrane domain containing member 5 (CMTM5) gene and the risk of coronary artery disease (CAD), and to detect the effects of CMTM5 gene expression changes on the ability of adhesion and migration of THP-1 cells. Methods: Using case-control method, a total of 700 hospitalized patients in Shijitan Hospital were enrolled in this study. CAD were diagnosed by coronary angiography, which was defined as at least one blood vessel diameter stenosis ≥50% according to the result of coronary angiography. Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect CMTM5 gene expression; enzyme linked immunosorbent assay (ELISA) method to detect the plasma level of CMTM5; and Logistic regression to analyze CMTM5 genes and the risk of CAD. Human vascular endothelial cells (ECs) and THP-1 cells were cultivated, adhesion and Transwells experiments were used to evaluate the chemotactic capabi-lity of CMTM5 gene on THP-1 cells. Results: In this study, 350 CAD patients matched with 350 control patients were included. RT-PCR results revealed CMTM5 mRNA expression in CAD group was 3.45 times compared with control group, which was significantly higher than that in control group (P<0.05). The levels of CMTM5 plasma protein in CAD group was (206.1±26.9) μg/L, which was significantly higher than that in control group (125.3±15.2) μg/L (P<0.05). After adjusted for the risk factors of age, gender, BMI, smoking, hypertension, diabetes and hyperlipidemia, Logistic regression analysis results indicated that CMTM5 was the susceptibility factors of CAD, which still had significant correlation with CAD (P<0.05). Adhesion and Transwells experiments results revealed that the numbers of adhesion and migration of THP-1 cells in CMTM5 overexpression ECs group (EO group) were significantly higher than that in lenti-mock infected ECs group (EO-MOCK group), non-infected ECs group (EN group), lenti-mock infected ECs group (ES-MOCK group), and CMTM5 suppression ECs group (ES group). On the contrary, the numbers of adhesion and migration of THP-1 cells in ES group were significantly lower than that in the other four groups (P<0.01). Conclusion: CMTM5 gene was closely related to the development of CAD. CMTM5 overexpression promoted the adhesion and migration of THP-1, which might play a part in the mechanisms of atherosclerosis and CAD.

Key words: Atherosclerosis, Coronary artery disease, CMTM5, Gene

CLC Number: 

  • R543.3

Table 1

Baseline characteristics of the patients in CAD group and control group"

Variables Control group (n=350) CAD group (n=350) P
Age/years, x-±s 58.2±7.3 58.7±8.2 0.535
Gender/(male/female), n 200/150 200/150 Match
BMI/(kg/m2), x-±s 25.0±4.0 25.3±5.3 0.525
DM, n (%) 32 (9.1) 79 (22.6) <0.001*
Hypertension, n (%) 185 (52.9) 220 (62.9) 0.013*
Current smoking, n (%) 115 (32.9) 170 (48.6) <0.001*
TG/(mmol/L), x-±s 2.15±1.02 2.24±1.30 0.002*
TC/(mmol/L), x-±s 4.72±1.05 5.03±1.61 <0.001*
LDL-C/(mmol/L), x-±s 2.52±0.62 2.63±0.83 0.013*
HDL-C/(mmol/L), x-±s 1.41±0.44 1.44±0.53 0.286

Figure 1

CMTM5 mRNA expression and its plasma level between CAD group and control group A, CMTM5 mRNA expression in the two groups; B, plasma level of CMTM5 in the two groups. * P<0.05. CAD, coronary artery disease."

Table 2

Logistic regression analysis of coronary artery disease risk factors"

Risk factors B SE OR 95%CI P
Lower Upper
Age -0.960 0.116 0.383 0.305 0.481 <0.001
Gender 0.567 0.067 1.763 1.546 2.010 <0.001
BMI -0.007 0.008 0.993 0.976 0.971 0.377
Smoking -0.822 0.070 0.439 0.383 0.504 <0.001
Hypertension 0.350 0.066 1.420 1.247 1.617 <0.001
Diabetes mellitus 0.579 0.052 1.784 1.611 1.975 <0.001
Hyperlipidemia 0.259 0.070 1.296 1.130 1.487 <0.001
CMTM5 -0.044 0.007 0.957 0.943 0.971 0.002

Figure 2

Effects of CMTM5 gene expression changes on THP-1 adhesion to ECs (fluorescence staining ×4) **P<0.01. EN, non-infected ECs group; EO, CMTM5 overexpression ECs group; EO-MOCK, lenti-mock infected ECs group; ES, CMTM5 suppression ECs group; ES-MOCK, lenti-mock infected ECs group; HPF, high-power field."

Figure 3

Effects of CMTM5 gene expression changes on THP-1 migration to ECs(Giemsa staining ×10) ** P<0.01. Abbreviations as in Figure 2."

[1] Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005,352(16):1685-1695.
doi: 10.1056/NEJMra043430 pmid: 15843671
[2] Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options[J]. Nat Med, 2011,17(11):1410-1422.
doi: 10.1038/nm.2538 pmid: 22064431
[3] Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach[J]. Cardiovasc Pathol, 2004,13(3):125-138.
pmid: 15081469
[4] Koenen RR, Weber C. Chemokines: established and novel targets in atherosclerosis[J]. EMBO Mol Med, 2011,3(12):713-725.
doi: 10.1002/emmm.201100183
[5] Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis[J]. Thromb Haemost, 2007,97(5):714-721.
pmid: 17479181
[6] Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update[J]. Arterioscler Thromb Vasc Biol, 2008,28(11):1897-1908.
doi: 10.1161/ATVBAHA.107.161174 pmid: 18566299
[7] Aukrust P, Halvorsen B, Yndestad A, et al. Chemokines and cardiovascular risk[J]. Arterioscler Thromb Vasc Biol, 2008,28(11):1909-1919.
doi: 10.1161/ATVBAHA.107.161240 pmid: 18669888
[8] Li H, Guo X, Shao L, et al. CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway[J]. BMB Rep, 2010,43(3):182-187.
pmid: 20356458
[9] Voora D, Cyr D, Lucas J, et al. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events[J]. J Am Coll Cardiol, 2013,62(14):1267-1276.
doi: 10.1016/j.jacc.2013.05.073 pmid: 23831034
[10] 刘滕飞, 张婧薇, 陈夏欢, 等. CMTM5基因rs723840单核苷酸多态性与阿司匹林治疗下血小板高反应性的相关性研究[J]. 北京大学学报(医学版), 2015,47(6):905-909.
doi: 10.3969/j.issn.1671-167X.2015.06.003
[11] Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation[J]. N Engl J Med, 2006,354(6):610-621.
doi: 10.1056/NEJMra052723 pmid: 16467548
[12] Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection[J]. Hepatology, 2009,49(2):676-688.
doi: 10.1002/hep.22763 pmid: 19177577
[13] Golay J, Introna M. Chemokines and antagonists in non-Hodgkin’s lymphoma[J]. Expert Opin Ther Targets, 2008,12(5):621-635.
doi: 10.1517/14728222.12.5.621 pmid: 18410244
[14] Tiemessen CT, Kuhn L. CC chemokines and protective immunity: insights gained from mother-to-child transmission of HIV[J]. Nat Immunol, 2007,8(3):219-222.
doi: 10.1038/ni0307-219 pmid: 17304227
[15] Dhami H, Fritz CE, Gankin B, et al. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies[J]. J Clin Pharm Ther, 2009,34(2):147-160.
doi: 10.1111/j.1365-2710.2008.00978.x pmid: 19250135
[16] Lundberg GA, Kellin A, Samnegard A, et al. Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene[J]. J Intern Med, 2005,257(5):415-422.
doi: 10.1111/j.1365-2796.2005.01469.x pmid: 15836657
[17] Singh N, Rai H, Sinha N, et al. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians[J]. Genet Test Mol Biomarkers, 2012,16(7):756-760.
doi: 10.1089/gtmb.2011.0256 pmid: 22731642
[18] Cai W, Tao J, Zhang X, et al. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 2014,34(9):1933-1941.
pmid: 24990231
[19] Zhang JW, Liu TF, Chen XH, et al. Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function[J]. Gene, 2017,624:56-65.
doi: 10.1016/j.gene.2017.04.041
[1] ZHU Xiao-ling,LI Wen-jing,WANG Xian-e,SONG Wen-li,XU Li,ZHANG Li,FENG Xiang-hui,LU Rui-fang,SHI Dong,MENG Huan-xin. Gene polymorphisms of cytochrome B-245 alpha chain (CYBA) and cholesteryl ester transfer protein (CETP) and susceptibility to generalized aggressive periodontitis [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 18-22.
[2] Hao XU,Guo-dong ZHANG,Guang-pu FAN,Yu CHEN. Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1139-1143.
[3] Dong-liang MU,Cheng XUE,Bin AN,Dong-xin WANG. Epidural block associated with improved long-term survival after surgery for colorectal cancer: A retrospective cohort study with propensity score matching [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1152-1158.
[4] Wen-yu DU,Jing-wen YANG,Ting JIANG. Early constant observation of the effect of deferoxamine mesylate on improvement of vascularized bone regeneration in SD rat skull critical size defect model [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1171-1177.
[5] Mei-ge LIU,Pu FANG,Yan WANG,Lu CONG,Yang-yi FAN,Yuan YUAN,Yan XU,Jun ZHANG,Dao-jun HONG. Clinical, pathological and genetic characteristics of 8 patients with distal hereditary motor neuropathy [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 957-963.
[6] Hong MENG,Li-na JI,Jing HUANG,Shuang CHAO,Jia-wen ZHOU,Xue-jun LI,Xiao-mei YIN,Li-rong FAN. Analysis of the changes and characteristics of pediatric outpatient visits in a general hospital in Beijing before and after the COVID-19 pandemic [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 952-956.
[7] Mei-xiang ZHANG,Wen-zhi SHI,Jian-xin LIU,Chun-jian WANG,Yan LI,Wei WANG,Bin JIANG. Clinical characteristics and prognosis of MLL-AF6 positive patients with acute myeloid leukemia [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 915-920.
[8] YOU Peng-yue,LIU Yu-hua,WANG Xin-zhi,WANG Si-wen,TANG Lin. Biocompatibility and effect on bone formation of a native acellular porcine pericardium: Results of in vitro and in vivo [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 776-784.
[9] FENG Ke,NI Jing-jing,XIA Yan-qing,QU Xiao-wei,ZHANG Hui-juan,WAN Feng,HONG Kai,ZHANG Cui-lian,GUO Hai-bin. Genetic analysis of three cases of acephalic spermatozoa syndrome caused by SUN5 mutation and the outcome of assisted reproductive technology [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 803-807.
[10] GUO Zi-ning, LIANG Zhi-sheng, ZHOU Yi, ZHANG Na, HUANG Jie. Genetic study of cardiovascular disease subtypes defined by International Classification of Diseases [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 453-459.
[11] ZHOU Chuan, MA Xue, XING Yun-kun, LI Lu-di, CHEN Jie, YAO Bi-yun, FU Juan-ling, ZHAO Peng. Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 602-607.
[12] ZHAO Kai,CHANG Zhi-fang,WANG Zhi-hua,PANG Chun-yan,WANG Yong-fu. Therapeutic effect of gene silencing peptidyl arginine deaminase 4 on pulmonary interstitial lesions induced by collagen-induced arthritis mice [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 235-239.
[13] HUANG Li-dong,GONG Wei-yu,DONG Yan-mei. Effects of bioactive glass on proliferation, differentiation and angiogenesis of human umbilical vein endothelial cells [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 371-377.
[14] WANG Si-wen,YOU Peng-yue,LIU Yu-hua,WANG Xin-zhi,TANG Lin,WANG Mei. Efficacy of two barrier membranes and deproteinized bovine bone mineral on bone regeneration in extraction sockets: A microcomputed tomographic study in dogs [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 364-370.
[15] WANG Jing-qi,WANG Xiao. In vivo study of strontium-doped calcium phosphate cement for biological properties [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 378-383.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[3] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[4] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[5] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 377 -380 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 381 -384 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 426 -428 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 432 -433 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd